GB9711125D0 - Novel cyanoguanidines - Google Patents

Novel cyanoguanidines

Info

Publication number
GB9711125D0
GB9711125D0 GBGB9711125.6A GB9711125A GB9711125D0 GB 9711125 D0 GB9711125 D0 GB 9711125D0 GB 9711125 A GB9711125 A GB 9711125A GB 9711125 D0 GB9711125 D0 GB 9711125D0
Authority
GB
United Kingdom
Prior art keywords
stands
alkoxycarbonyl
trifluoromethyl
carboxy
cyano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9711125.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMACEUTICAL PROD Ltd
Leo Pharma AS
Original Assignee
PHARMACEUTICAL PROD Ltd
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMACEUTICAL PROD Ltd, Leo Pharmaceutical Products Ltd AS filed Critical PHARMACEUTICAL PROD Ltd
Priority to GBGB9711125.6A priority Critical patent/GB9711125D0/en
Publication of GB9711125D0 publication Critical patent/GB9711125D0/en
Priority to NZ501071A priority patent/NZ501071A/en
Priority to RO99-01251A priority patent/RO120541B1/ro
Priority to JP50011499A priority patent/JP4408455B2/ja
Priority to HU0002921A priority patent/HUP0002921A3/hu
Priority to HK00106580.3A priority patent/HK1027562B/xx
Priority to DE69818041T priority patent/DE69818041T2/de
Priority to PCT/DK1998/000196 priority patent/WO1998054144A1/en
Priority to CA002292895A priority patent/CA2292895C/en
Priority to PT98924055T priority patent/PT984938E/pt
Priority to CN98805595A priority patent/CN1116283C/zh
Priority to AU76386/98A priority patent/AU733142B2/en
Priority to PL98337030A priority patent/PL190314B1/pl
Priority to RU99128082/04A priority patent/RU2195453C2/ru
Priority to EP98924055A priority patent/EP0984938B1/en
Priority to KR10-1999-7011131A priority patent/KR100496220B1/ko
Priority to CZ19994234A priority patent/CZ294842B6/cs
Priority to DK98924055T priority patent/DK0984938T3/da
Priority to US09/424,632 priority patent/US6346541B1/en
Priority to AT98924055T priority patent/ATE249438T1/de
Priority to ES98924055T priority patent/ES2206932T3/es
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB9711125.6A 1997-05-29 1997-05-29 Novel cyanoguanidines Pending GB9711125D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB9711125.6A GB9711125D0 (en) 1997-05-29 1997-05-29 Novel cyanoguanidines
ES98924055T ES2206932T3 (es) 1997-05-29 1998-05-15 Cianoguanidinas como inhibidores de la proliferacion celular.
CN98805595A CN1116283C (zh) 1997-05-29 1998-05-15 作为细胞增殖抑制剂的氰基胍
PL98337030A PL190314B1 (pl) 1997-05-29 1998-05-15 Cyjanoguanidyny jako inhibitory proliferacji komórki, preparat farmaceutyczny, sposób wytwarzania cyjanoguanidyn oraz ich zastosowanie
JP50011499A JP4408455B2 (ja) 1997-05-29 1998-05-15 細胞増殖抑制剤としてのシアノグアニジン
HU0002921A HUP0002921A3 (en) 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors, process for producing them and pharmaceutical compositions containing them
HK00106580.3A HK1027562B (en) 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors
DE69818041T DE69818041T2 (de) 1997-05-29 1998-05-15 Cyanoguanidine als zellproliferation inhibitoren
PCT/DK1998/000196 WO1998054144A1 (en) 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors
CA002292895A CA2292895C (en) 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors
PT98924055T PT984938E (pt) 1997-05-29 1998-05-15 Cianoguanidinas como inibidores da proliferacao celular
NZ501071A NZ501071A (en) 1997-05-29 1998-05-15 Cyanoguanidines such as N-cyano-N'-(5-phenylaminocarbonylpentyl)-N'-4-pyridylguanidine for treating skin cancer or cancer cells
AU76386/98A AU733142B2 (en) 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors
RO99-01251A RO120541B1 (ro) 1997-05-29 1998-05-15 Derivaţi de cianoguanidină, ca inhibitori ai proliferării celulelor
RU99128082/04A RU2195453C2 (ru) 1997-05-29 1998-05-15 Цианогуанидины, способы их получения и фармацевтический препарат на их основе
EP98924055A EP0984938B1 (en) 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors
KR10-1999-7011131A KR100496220B1 (ko) 1997-05-29 1998-05-15 세포 증식 억제제로서의 시아노구아니딘
CZ19994234A CZ294842B6 (cs) 1997-05-29 1998-05-15 Kyanoguanidiny, způsob jejich přípravy a použití a farmaceutické přípravky s jejich obsahem
DK98924055T DK0984938T3 (da) 1997-05-29 1998-05-15 Cyanoguanidiner som celleproliferationsinhibitorer
US09/424,632 US6346541B1 (en) 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors
AT98924055T ATE249438T1 (de) 1997-05-29 1998-05-15 Cyanoguanidine als zellproliferation inhibitoren

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9711125.6A GB9711125D0 (en) 1997-05-29 1997-05-29 Novel cyanoguanidines

Publications (1)

Publication Number Publication Date
GB9711125D0 true GB9711125D0 (en) 1997-07-23

Family

ID=10813255

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9711125.6A Pending GB9711125D0 (en) 1997-05-29 1997-05-29 Novel cyanoguanidines

Country Status (20)

Country Link
US (1) US6346541B1 (enExample)
EP (1) EP0984938B1 (enExample)
JP (1) JP4408455B2 (enExample)
KR (1) KR100496220B1 (enExample)
CN (1) CN1116283C (enExample)
AT (1) ATE249438T1 (enExample)
AU (1) AU733142B2 (enExample)
CA (1) CA2292895C (enExample)
CZ (1) CZ294842B6 (enExample)
DE (1) DE69818041T2 (enExample)
DK (1) DK0984938T3 (enExample)
ES (1) ES2206932T3 (enExample)
GB (1) GB9711125D0 (enExample)
HU (1) HUP0002921A3 (enExample)
NZ (1) NZ501071A (enExample)
PL (1) PL190314B1 (enExample)
PT (1) PT984938E (enExample)
RO (1) RO120541B1 (enExample)
RU (1) RU2195453C2 (enExample)
WO (1) WO1998054144A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711123D0 (en) * 1997-05-29 1997-07-23 Leo Pharm Prod Ltd Novel cyanoguanidines
AU4080300A (en) 1999-04-09 2000-11-14 Shionogi Bioresearch Corp. Cyanoguanidine compounds
AU1494702A (en) 2000-11-21 2002-06-03 Leo Pharma As Cyanoguanidine prodrugs
US20030045515A1 (en) * 2001-05-24 2003-03-06 Lise Binderup Combination medicament for treatment of neoplastic diseases
PL366459A1 (en) * 2001-05-24 2005-02-07 Leo Pharma A/S Novel pyridyl cyanoguanidine compounds
CA2484671A1 (en) * 2002-05-17 2003-11-27 Leo Pharma A/S Cyanoguanidine prodrugs
US7253193B2 (en) 2002-05-17 2007-08-07 Leo Pharma A/S Cyanoguanidine prodrugs
RU2326867C2 (ru) * 2002-05-17 2008-06-20 Лео Фарма А/С Цианогуанидиновые производные, способ лечения и фармацевтическая композиция на их основе
WO2006037468A1 (en) * 2004-09-30 2006-04-13 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Hiv reverse transcriptase inhibitors
CA2594508C (en) * 2004-12-22 2013-10-01 Leo Pharma A/S Cyanoguanidine compounds
JP2008535822A (ja) * 2005-03-25 2008-09-04 グラクソ グループ リミテッド 新規化合物
EP2197443A4 (en) 2007-09-26 2014-01-01 Gemin X Pharmaceuticals Canada Inc COMPOSITIONS AND METHOD FOR LEADING NAD + MIRRORS USING A NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE HEMMER
US8173677B2 (en) 2007-09-26 2012-05-08 Gemin X Pharmaceuticals Canada Inc. Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl transferase inhibitor
WO2009086835A1 (en) * 2008-01-11 2009-07-16 Topotarget A/S Novel cyanoguanidines
CN102186822A (zh) * 2008-08-29 2011-09-14 顶标公司 新脲和硫脲衍生物
EP2394649A4 (en) * 2009-02-06 2012-08-15 Tianjin Hemay Bio Tech Co Ltd PHARMACEUTICAL COMPOSITIONS CONTAINING PYRIDYL-CYANOGUANIDINES, PREPARATION METHODS AND USES THEREOF
US8912184B1 (en) 2010-03-01 2014-12-16 Alzheimer's Institute Of America, Inc. Therapeutic and diagnostic methods
TW201216963A (en) 2010-09-03 2012-05-01 Forma Therapeutics Inc Novel compounds and compositions for the inhibition of NAMPT
WO2012055346A1 (zh) 2010-10-26 2012-05-03 天津和美生物技术有限公司 N-(6-(4-氯苯氧基)己基)-n'-氰基-n''-(4-吡啶基)胍的多晶型物及其制备和应用
MA46660A (fr) 2016-10-18 2019-08-28 Seattle Genetics Inc Administration ciblée d'inhibiteurs de la voie de récupération de nicotinamide adénine dinucléotide
JP7425606B2 (ja) 2017-04-27 2024-01-31 シージェン インコーポレイテッド 四級化ニコチンアミドアデニンジヌクレオチドサルベージ経路阻害剤コンジュゲート

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4530693A (en) * 1992-08-13 1994-03-15 Upjohn Company, The Cyanoguanidines as potassium channel blockers
GB9219472D0 (en) * 1992-09-15 1992-10-28 Leo Pharm Prod Ltd Chemical compounds
JPH09508382A (ja) * 1994-01-28 1997-08-26 ジ・アップジョン・カンパニー Ｋ−チャネル遮断薬用シアノグアニジン類

Also Published As

Publication number Publication date
CA2292895C (en) 2007-03-06
ATE249438T1 (de) 2003-09-15
DK0984938T3 (da) 2004-01-12
PL337030A1 (en) 2000-07-31
KR100496220B1 (ko) 2005-06-21
RU2195453C2 (ru) 2002-12-27
HK1027562A1 (en) 2001-01-19
NZ501071A (en) 2001-08-31
WO1998054144A1 (en) 1998-12-03
DE69818041D1 (de) 2003-10-16
CN1258279A (zh) 2000-06-28
HUP0002921A2 (hu) 2001-01-29
EP0984938B1 (en) 2003-09-10
HUP0002921A3 (en) 2002-10-28
CN1116283C (zh) 2003-07-30
US6346541B1 (en) 2002-02-12
JP2001526694A (ja) 2001-12-18
CZ9904234A3 (cs) 2001-02-14
RO120541B1 (ro) 2006-03-30
EP0984938A1 (en) 2000-03-15
PT984938E (pt) 2004-02-27
CZ294842B6 (cs) 2005-03-16
AU7638698A (en) 1998-12-30
DE69818041T2 (de) 2004-07-08
PL190314B1 (pl) 2005-11-30
KR20010013148A (ko) 2001-02-26
CA2292895A1 (en) 1998-12-03
ES2206932T3 (es) 2004-05-16
JP4408455B2 (ja) 2010-02-03
AU733142B2 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
GB9711125D0 (en) Novel cyanoguanidines
NZ508990A (en) Pyrazoline derivatives, their preparation and application as medicaments
BG104248A (en) Benzamidoxim derivatives, intermediate products and methods for preparing and using them as fungicides
MY112232A (en) Indole derivatives
BG106116A (en) 5-cyano-2-aminopyrimidine derivatives
WO2002087513A3 (en) Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
PL338452A1 (en) Novel substituted 6-phenylphenatridines
IL108769A0 (en) Spirocyclic piperidine derivatives
WO2001062705A8 (en) Aminoalcohol derivatives
BG103867A (en) Cyanoguanidines as cell proliferation inhibitors
BR9405910A (pt) Piridinas substituídas heterocíclicas herbicidas
CA2214759A1 (en) Intimal hypertrophy inhibitors
MXPA03009750A (es) Compuestos quimicos.
IL158574A0 (en) Novel pyridyl cyanoguanidine compounds
DE60025848D1 (en) Pyrimidin-derivate als selective inhibitoren von cox-2
GB9711123D0 (en) Novel cyanoguanidines
WO2002014281A8 (en) Pyridine derivatives as inhibitors of p38
NO20000957L (no) Forgrenede alkoksy-substituerte 2-aminopyridiner som NOS inhibitorer
DE69720715D1 (en) Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel
IL180312A0 (en) Process for preparing carboxamide pyridine derivatives used as intermediates in the synthesis of nk-1 recepor antagonists
EA200001009A1 (ru) Производные пиридина, ингибирующие фосфодиэстеразу iv
BG105089A (en) 2-aminopyridines containing fused ring substituents as nitric oxide synthesis inhibitors
MXPA04004450A (es) Nuevos compuestos y composiciones como inhibidores de catepsina s.
IL123692A (en) Phenanthridine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
UA74404C2 (uk) Похідні піридинзаміщених піразолопіридинів